Randomized control trial investigating the influence of coffee on heart rate variability in patients with ST-segment elevation myocardial infarction.

BACKGROUND Cardiac autonomic dysfunction post ST-segment elevation myocardial infarction (STEMI) has been linked to an excess risk of premature cardiovascular morbidity and mortality above those with normal autonomic function post-STEMI. AIM The aim of this study was to evaluate the effect of acute ingestion of coffee on autonomic function and cardiovascular outcomes in patients with acute STEMI. DESIGN Randomized control trial. METHODS We randomized 103 patients with acute STEMI, admitted to our Coronary Care Unit, to receive regular coffee (caffeinated) or de-caffeinated coffee using a randomized controlled double-blinded design. Heart rate variability was assessed 5 days post-STEMI to assess the effect of caffeine on autonomic function. RESULTS In the group randomized to regular coffee, parasympathetic activity increased by up to 96% (P = 0.04) after 5 days. There was no detrimental effect of regular coffee on cardiac rhythm post-STEMI. CONCLUSION Coffee ingestion is associated with an increase in parasympathetic autonomic function immediately post-STEMI. Coffee was found to be safe and not associated with any adverse cardiovascular outcomes in the short term.

[1]  F. Hu,et al.  Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes , 2009, Diabetologia.

[2]  I. Janszky,et al.  Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. , 2009, American heart journal.

[3]  B. Gersh.  The Relationship of Coffee Consumption with Mortality , 2009 .

[4]  F. Violi,et al.  Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. , 2008, The British journal of nutrition.

[5]  L. Tavazzi,et al.  Coffee Consumption and Risk of Cardiovascular Events After Acute Myocardial Infarction: Results From the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico)-Prevenzione Trial , 2007, Circulation.

[6]  Maria GiuseppinaSilletta,et al.  Coffee Consumption and Risk of Cardiovascular Events After Acute Myocardial Infarction , 2007 .

[7]  A. El-Sohemy,et al.  Coffee, CYP1A2 genotype, and risk of myocardial infarction. , 2006, JAMA.

[8]  F. Sofi,et al.  Coffee consumption and risk of coronary heart disease: a meta-analysis. , 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[9]  J. Muller,et al.  Caffeinated coffee consumption and mortality after acute myocardial infarction. , 2004, American heart journal.

[10]  Jacqueline Ryder,et al.  Influence of caffeine on heart rate variability in patients with long-standing type 1 diabetes. , 2004, Diabetes care.

[11]  C. Antzelevitch,et al.  Autonomic aspects of arrhythmogenesis: the enduring and the new , 2004, Current opinion in cardiology.

[12]  D. Treré,et al.  Parasympathetic failure and risk of subsequent coronary events in unstable angina and non-ST-segment elevation myocardial infarction. , 2003, European heart journal.

[13]  Pekka Raatikainen,et al.  Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. , 2003, Journal of the American College of Cardiology.

[14]  Ralph J. Verdino,et al.  Changes in heart rate and heart rate variability before ambulatory ischemic events , 2001 .

[15]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[16]  T. Feldman,et al.  Gender differences and the outcome of interventions for acute coronary syndromes. , 2000, Cardiology in review.

[17]  K. Thygesen,et al.  Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring. TRIM study group. Thrombin Inhibition in Myocardial Ischemia. , 1999, Journal of the American College of Cardiology.

[18]  A. Rebuzzi,et al.  Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. , 1999, Circulation.

[19]  J. Parrillo,et al.  Improved risk stratification in unstable angina: Identification of patients at low risk for in‐hospital cardiac events by admission echocardiography , 1998, Clinical cardiology.

[20]  J. Eisenberg,et al.  Views from funding agencies. Agency for Health Care Policy and Research. , 1998, Medical care.

[21]  K. Fox,et al.  Long-term prognosis in unstable angina. The importance of early risk stratification using continuous ST segment monitoring. , 1998, European heart journal.

[22]  L. Lindblad,et al.  Heart rate variability as a means of assessing prognosis after acute myocardial infarction. A 3-year follow-up study. , 1997, European heart journal.

[23]  A. Jaffe,et al.  Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. , 1997, Circulation.

[24]  J. Le Heuzey,et al.  Effects of bisoprolol on heart rate variability in heart failure. , 1996, The American journal of cardiology.

[25]  R. Bugiardini,et al.  Transient sympathovagal imbalance triggers "ischemic" sudden death in patients undergoing electrocardiographic Holter monitoring. , 1996, Journal of the American College of Cardiology.

[26]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[27]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[28]  H. Roberts,et al.  Caffeine consumption. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[29]  H. Kulbertus.  [Long-term prognosis in unstable angina]. , 1995, Praxis.

[30]  Daniel B. Mark,et al.  Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. , 1994, Circulation.

[31]  D. Bonaduce,et al.  Effects of Converting Enzyme Inhibition on Heart Period Variability in Patients With Acute Myocardial Infarction , 1994, Circulation.

[32]  V. Fuster,et al.  Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. , 1994, Circulation.

[33]  J. Miller,et al.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.